Table 1.
Frequency (%) | ||
---|---|---|
Age |
Median (SD) |
65.00 y (8.3y) |
|
Range |
40-84y |
Marital status |
Single |
18 (8.4%) |
|
Partnership, marriage |
135 (63.1%) |
|
Divorced, separated |
28 (13.1%) |
|
Widowed |
33 (15.4%) |
Employment status |
Full-time |
16 (7.5%) |
|
Part-time |
16 (7.5%) |
|
Unemployed |
5 (2.1%) |
|
Homemaker |
31 (14.5%) |
|
Retired |
142 (66.4%) |
|
Other |
4 (1.6%) |
Histological classification |
Invasive |
226 (93.4%) |
|
In situ |
15 (6.2%) |
|
Missing |
1 (0.4%) |
Grading |
Grade I |
35 (14.5%) |
|
Grade II |
176 (72.7%) |
|
Grade III |
10 (4.1%) |
|
Unknown |
21 (8.7%) |
Duration of adjuvant endocrine therapy (months) |
Median (SD) |
26.7 (19.1) mo. |
|
Range |
0.7- 89.5 mo. |
Primary surgical treatment |
Breast-conserving procedure |
155 (65.7%) |
|
Mastectomy |
81 (34.3%) |
|
Reconstruction |
43 (18.2%) |
Chemotherapy |
|
41 (16.9%) |
Radiotherapy | 169 (71.3%) |